TY - JOUR
T1 - Mitochondrial β-oxidation of adiposederived fatty acids by osteoblasts fuels parathyroid hormone-induced bone formation
AU - Alekos, Nathalie S.
AU - Kushwaha, Priyanka
AU - Kim, Soohyun P.
AU - Li, Zhu
AU - Abood, Abdullah
AU - Dirckx, Naomi
AU - Aja, Susan
AU - Kodama, Joe
AU - Garcia-Diaz, Jean G.
AU - Otsuru, Satoru
AU - Rendina-Ruedy, Elizabeth
AU - Wolfgang, Michael J.
AU - Riddle, Ryan C.
N1 - Publisher Copyright:
© 2023, Alekos et al.
PY - 2023/3/22
Y1 - 2023/3/22
N2 - The energetic costs of bone formation require osteoblasts to coordinate their activities with tissues, like adipose, that can supply energy-dense macronutrients. In the case of intermittent parathyroid hormone (PTH) treatment, a strategy used to reduce fracture risk, bone formation is preceded by a change in systemic lipid homeostasis. To investigate the requirement for fatty acid oxidation by osteoblasts during PTH-induced bone formation, we subjected mice with osteoblastspecific deficiency of mitochondrial long-chain β-oxidation as well as mice with adipocyte-specific deficiency for the PTH receptor or adipose triglyceride lipase to an anabolic treatment regimen. PTH increased the release of fatty acids from adipocytes and β-oxidation by osteoblasts, while the genetic mouse models were resistant to the hormone's anabolic effect. Collectively, these data suggest that PTH's anabolic actions require coordinated signaling between bone and adipose, wherein a lipolytic response liberates fatty acids that are oxidized by osteoblasts to fuel bone formation.
AB - The energetic costs of bone formation require osteoblasts to coordinate their activities with tissues, like adipose, that can supply energy-dense macronutrients. In the case of intermittent parathyroid hormone (PTH) treatment, a strategy used to reduce fracture risk, bone formation is preceded by a change in systemic lipid homeostasis. To investigate the requirement for fatty acid oxidation by osteoblasts during PTH-induced bone formation, we subjected mice with osteoblastspecific deficiency of mitochondrial long-chain β-oxidation as well as mice with adipocyte-specific deficiency for the PTH receptor or adipose triglyceride lipase to an anabolic treatment regimen. PTH increased the release of fatty acids from adipocytes and β-oxidation by osteoblasts, while the genetic mouse models were resistant to the hormone's anabolic effect. Collectively, these data suggest that PTH's anabolic actions require coordinated signaling between bone and adipose, wherein a lipolytic response liberates fatty acids that are oxidized by osteoblasts to fuel bone formation.
UR - http://www.scopus.com/inward/record.url?scp=85150751368&partnerID=8YFLogxK
U2 - 10.1172/jci.insight.165604
DO - 10.1172/jci.insight.165604
M3 - Article
C2 - 36729662
AN - SCOPUS:85150751368
SN - 2379-3708
VL - 8
JO - JCI Insight
JF - JCI Insight
IS - 6
M1 - e165604
ER -